{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-011706","form_type":"8-K","ticker":"ACAD","cik":"0001070494","company_name":"ACADIA PHARMACEUTICALS INC","filed_at":"2026-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.498636+00:00","generated_at":"2026-05-16T10:33:16.717517+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Acadia Pharmaceuticals reaffirms 2025 net sales guidance above $1B","bullets":["Anticipates 2025 net sales will exceed $1 billion, consistent with prior guidance.","Presented at J.P. Morgan Healthcare Conference on January 13, 2026.","Corporate slide presentation posted on ir.acadia.com for investor access."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-011706","json":"https://secwatch.observer/filing/0001193125-26-011706.json","markdown":"https://secwatch.observer/filing/0001193125-26-011706.md","text":"https://secwatch.observer/filing/0001193125-26-011706.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1070494/000119312526011706/0001193125-26-011706-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1070494/000119312526011706/acad-20260113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:33:16.717517+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}